Atlas Trials

Effects of DL-3-n-butylphthalide on Chemotherapy-Induced Cognitive Impairment

Clinical trial NCT06508671 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06508671
Sponsor
First Hospital of China Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Chemotherapy-Related Cognitive ImpairmentDL-3-n-butylphthalide
Start date
2024-07-01
Primary completion
2025-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.